• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Affle 3i Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
542752
INE00WC01027
145.8552559
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AFFLE
152.17
20375.35
EPS(TTM)
Face Value()
Div & Yield %
9.51
2
0
 

technvision ventures ltd
Lactose India spurts after Q4 PAT climbs 194% YoY to Rs 2 cr
May 20,2026
Revenue from operations soared 64.81% year-on-year to Rs 45.77 crore in the quarter ended 31 March 2026.

Total expenses increased 58.28% year-on-year to Rs 43.67 crore during the quarter, compared with Rs 27.59 crore in the year-ago period. The cost of materials consumed stood at Rs 28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to Rs 3.53 crore.

Profit before tax (PBT) stood at Rs 2.31 crore in Q4 FY26, registering a growth of 320% from Rs 0.55 crore reported in Q4 FY25.

For the full financial year FY26, the company posted a 17.44% rise in consolidated net profit to Rs 6.06 crore, while revenue rose 40.28% to Rs 163.29 crore compared with FY25.

Lactose (India) is a pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products.